Inborn Errors Of Metabolism Flashcards

1
Q

What are inborn errors of metabolism (IEM)?

A
  • IEM = Group of rare genetic disorders
  • Single gene defects -> deficient or absent activity of an enzyme -> results in disruption to metabolic pathways
  • Affects syntheses/catabolism of proteins, carbs, fats and complex molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give some key features of IEM

A
  • Individually rare (e.g PKU 1:10,000)
  • Collectively common (1:800 to 1:2500)
  • High mortality within the first year of life
  • Significant contribution to children of school age with physical handicap and children with severe learning difficulties
  • Important to recognise in sick neonate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is IEM treated?

A
  • Global newborn screening programmes
  • Treatment by dietary control/restrictions and/or compound supplementation. Newer drug and enzyme replacement therapy, and organ transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

State what the effects of IEM arise from (4) ?

A
  1. Toxic accumulation of substrates
  2. Toxic accumulation of intermediates from alternative metabolic pathways
  3. Defects in energy production/use due to deficiency of products
  4. Combination of above
    - Can vary in age of onset and clinical severity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the Difference between congenital and inborn?

A
  • Congenital = Present at birth
  • Inborn = Transmitted through gametes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State 2 features of alkaponuria

A
  • Autosomal recessive disease
  • Congenital
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State 2 symptoms and 2 causes of alkaponuria

A
  • Symptoms: Urine turns black on standing, Black ochrontic pigmentation cartilage and collagenous tissue
  • Causes: Homogentisic acid oxidase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State the one gene - one enzyme concept?

A
  • All biochemical processes in all organisms are under genetic control
  • Biochemical processes are resolvable into a series of stepwise reactions
  • Each biochemical reaction is under the ultimate control of a different single gene
  • Mutation of a single gene results in an alteration in the ability of the cell to carry out a single primary chemical reaction -> affects metabolic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does the one gene- one enzyme concept link with the molecular disease concept in IEM?

A
  • Molecular disease concept: Direct evidence that human gene mutations produce an alteration in the primary structure of proteins.
  • Inborn errors of metabolism are caused by mutations in genes which then produce abnormal proteins whose functional activities are altered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inheritance patterns
State the different mechanisms of inheritance of IEM?

A
  • Autosomal recessive
  • Autosomal dominant
  • X-linked
  • Mitochondrial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe autosomal recessive as a mechanism of inheritance and give 3 examples of AR IEM?

A
  • Both parents carry a mutation affecting the same gene
  • 1 in 4 risk each pregnancy
  • Consanguinity (same blood) increases risk of autosomal recessive conditions
  • Examples: PKU (phenylketonuria), alkaponuria, MCADD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is autosomal dominant rare in IMs and state 2 examples?

A
  • Rare in IEM
  • Examples: Marfan’s, acute intermittent porphyria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe how the X-linked conditions pass through each gender and state 2 examples of X-linked IEMs?

A
  • Recessive X linked conditions passed through the maternal line
  • Condition appears in males
  • Condition carried in females
  • Female carriers may manifest condition - Lyonisation (random inactivation of one of the X chromosomes)
  • Examples: Fabry’s disease, Ornithine carbonyl transferase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is mitochondrial gene mutation and describe how mitochondrial inheritance occurs?

A
  • Mitochondrial gene DNA mutation -> Causes M to fail to produce energy to function properly
  • M DNA is inherited exclusively from mother
  • Only the egg contributes mitochondria to the developing embryo
  • Only females can pass on mitochondrial mutations to their children
  • Fathers do not pass these disorders to their daughters or sons
  • Affects both male and female offspring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State 2 examples of mitochondrial mutation IEM disorders with symptoms?

A
  • MERFF -Myoclonic epilepsy and ragged red fibre disease:
  • deafness, dementia, seizures
  • MELAS - Mitochondrial encephalopathy with lacticacidosis and stroke-like episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can be the result when mitochondrial DNA replication occurs when a mitochondrial mutation has been inherited?

A
  • Heteroplasmy occurs - Cells contain varying amounts of normal mtDNA and also mutated mt DNA (heteroplasmic cells)
17
Q

How can the mitochondrial disease differ between individuals?

A
  • Distribution of affected mitochondria determines presentation
  • Mitochondrial disease can vary in symptoms, severity, age of onset
  • High energy-requiring organs more frequently affected
18
Q

State the major classifications of IEM with examples of diseases for each one?

A
  • Toxic Accumulation
  • Deficiency in energy Production/Utilization
  • Disorders of complex molecules involving organelles
19
Q

Describe toxic accumulation

A
  • Protein metabolism:
  • Amino acids e.g. PKU, tyrosinaemia
  • Organic acids e.g. propionylacidaemia
  • Urea cycle disorders e.g. OTCD
  • Carbohydrate intolerance e.g. galactosaemia
20
Q

Describe Deficiency in energy production/utilization

A
  • Fatty acid oxidation e.g. MCADD
  • Carbohydrate utilization/production e.g. GSDs
  • Mitochondrial disorders e.g. MERFF
21
Q

Describe Disorders of complex molecules involving organelles

A
  • Lyososomal storage disorders e.g. Fabry’s
  • Peroxisomal disorders e.g. Zellwegers
22
Q

How does onset of neonate and adult of IEM differ?

A
  • Neonatal to adult onset depending on severity of metabolic defect:
  • Neonatal presentation often acute
  • Often caused by defects in carbohydrate intolerance and energy metabolism
23
Q

How does onset of neonate and adult of IEM differ?

A
  • Late-onset due to accumulation of toxic molecules
  • Patients have residual enzyme activity allowing slower accumulation of toxins
  • Symptoms appear at adulthood
  • Present with organ failure, encepalopathy, seizures
24
Q

Neonates with IM, how are they born like and state clues for IEM?

A
  • May be born at term with normal birth weight and no abnormal features
  • Symptoms present frequently in the first week of life when starting full milk feeds
  • Clues for IEMs: Consanguinity, Family history of similar illness in siblings or unexplained deaths, Infant who was well at birth but starts to deteriorate for no obvious reason
25
Q

State clinical symptoms of neonates with IM?

A
  • Poor feeding, lethargy, vomiting
  • Epileptic encephalopathy
  • Profound hypotonia -‘floppy’ baby
  • Organomegaly e.g. cardiomyopathy, hepatomegaly
  • Dysmorphic features - abnormality in shape of part of body
  • Sudden unexpected death in infancy (SUDI)
26
Q

State biochemical abnormalities found in neonates with IEM

A
  • Hypoglycaemia
  • Hyperammonaemia
  • Unexplained metabolic acidosis / ketoacidosis
  • Lactic acidosis
27
Q

Lab testing
State 3 routine lab investigations for IEM?

A
  • Blood gas analysis
  • Blood glucose and lactate
  • Plasma ammonia
28
Q

Lab testing
State 6 specialist investigations for IM?

A
  • Plasma amino acids
  • Urinary organic acids + orotic acid
  • Blood acvl carnitine
  • Urinary glycosaminoglycans
  • Plasma very long chain fatty acids
  • CSF tests e.g. CS lactate/pyruvate, neurotransmitters
29
Q

State 4 confirmatory tests for IEM?

A
  • Enzymology: Red cell galactose-1-phosphate uridyl transferase for galactosaemia, Lysosomal enzyme screening for Fabry’s
  • Biopsy (muscle, liver)
  • Fibroblast studies
  • Mutation analysis - whole genome sequencing for FH
30
Q

State the criteria required for a successful screening programme?

A
  • Condition should be an important health problem
  • Must know incidence/prevelence in screening population
  • Natural history of the condition should be understood:
  • There should be a recognisable latent or early symptomatic stage
  • Availability of a screening test that is easy to perform and interpret:
  • acceptable, accurate, reliable, sensitive and specific
  • Availability of an accepted treatment for the condition:
  • More effective if treated earlier
  • Diagnosis and treatment of the condition should be cost-effective
31
Q

State the disorders tested for in the UK newborn blood spot screening programme?

A
  • Initial National programme included: PKU! Congenital hypothyroidism
  • Extended to include: Sickle cell disease, Cystic fibrosis, Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
  • From 2015, the screening in England expanded to include four additional conditions (analysis by tandem mass spectrometry): Maple syrup urine disease (MSUD), Homocystinuria (pyridoxine unresponsive) (HCU), Isovaleric acidaemia (IVA), Glutaric aciduria type 1 (GA1)
32
Q

Describe how the newborn blood spot screening occurs?

A
  • Samples taken on day 5 after birth
  • Taken from heel prick
  • All four circle on ‘Guthrie’ card must be completely filled with single drop of blood
  • UK national screening programme centre regulates this all
33
Q

Neonatal causes
What are some possible metabolic causes for acute liver disease in neonate

A
  • Classical galactosaemia
  • Hereditary fructose intolerance g An organic acidaemia
  • Tyrosinaemia type 1
  • Urine organic acid analysis showed increase in succinylacetone
  • Confirmation by sequence analysis of gene
34
Q

Describe Tyrosinaemia Type 1

A
  • Genetic deficiency in fumarylacetoacetase (FAH)
  • Catalyzes the final step in tyrosine metabolism.
  • Increased byproduct succinylacetone leads to significant organ toxicity (liver, kidney)
  • Treatment with Nitisinone (NTBC)
  • inhibits an earlier step in the pathway to prevent accumulation of toxic metabolites
  • early treatment achieves >90% survival rate with normal growth, improved liver function and prevention of cirrhosis
  • NTBC side effect is accumulation of tyrosine, and requires dietary restriction of tyrosine and precursor phenylalanine
35
Q

Late onset case
What types of diagnostic biopsies can be taken?

A
  • Diagnostic test - liver biopsy
  • Liver enzymology
  • Ornithine transcarbamylase 1.00 (ref range 11.8 - 44.7)
  • Carbamylphosphate synthase 0.98 (ref range 0.73 - 3.19)
36
Q

Describe Ornithine transcarbamylase deficiency

A
  • Urea cycle disorder, OTC incidence 1:14000
  • Symptoms range from mild to profound neuropsychiatric manifestations
  • Ataxia, seizures, hyperammmonaemic encephalopathy
  • Factors can trigger hyperammonaemic crisis
  • Increased endogenous protein catabolism e.g. infection, fasting, trauma, steroid administration
  • High protein intake (too much cheese intake)
  • The mother remembers that on the day of the collapse, their fridge had been full of cheese in the morning, but empty in the evening!